MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|136|12|2844-2853

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.12, 2015-06, pp. : 2844-2853

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1677-1685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles

By  

Oncology, Vol. 80, Iss. 1-2, 2011-05 ,pp. : 12-20

Karger

Access to resources Recommend Favorite

Towards new response criteria in neuroendocrine tumors: Which changes in MRI parameters are associated with longer progression‐free survival after radioembolization of liver metastases?

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 2, 2015-02 ,pp. : 361-368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 504-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Confounding Factors in Diagnostics of MGMT Promoter Methylation Status in Glioblastomas in Stereotactic Biopsies

By  

Stereotactic and Functional Neurosurgery, Vol. 92, Iss. 3, 2014-04 ,pp. : 129-139

Karger

Access to resources Recommend Favorite